Frank Mühlenbeck


Frank is a Partner and Head of Europe in Gold Nest Capital. He has also been a Managing Director at EMBL Ventures since 2015, focusing on opportunities in the life science and medical device sector.

Prior to joining EMBL, Frank was a partner at aeris CAPITAL (now Calibrium), a family office in Switzerland. At aeris he was responsible for investments in life science companies in Europe and the US and represented aeris on various portfolio boards, including Curetis AG, ION Torrent Inc., Sonetik AG, Affimed Therapeutics AG and ConforMis Inc. Prior he was with Steinbeis, a German technology transfer institution where Frank worked for life science start-ups and investors including public institutions KfW and tbg.

Frank studied technical biology at the University of Stuttgart, Germany and obtained a doctoral degree in cell biology and immunology.